Digital Transformation Opportunities Corp. DTOC
Institutional shares held
49,584
0
calls
0
puts
Total value of holdings
$0
$0
calls
$0
puts
Market Cap
N/A
Institutional ownership
0.15%
# of Institutions
1
We take great care to ensure that the data presented and summarized in this overview for Digital Transformation Opportunities Corp. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding DTOC
View allLatest Institutional Activity in DTOC
Top Purchases
Top Sells
About DTOC
Digital Transformation Opportunities Corp., a blank check company, intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses or entities. The company was founded in 2020 and is based in Bellevue, Washington.
Insider Transactions at DTOC
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|
Jul 16
2024
|
Stephen Divers Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,000
+26.77%
|
-
|
|
Jul 16
2024
|
Bradley M Fluegel Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+10.0%
|
-
|
|
Jul 16
2024
|
William Valle Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+20.02%
|
-
|
|
Jul 16
2024
|
David Afshar Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+50.0%
|
-
|
|
Jul 16
2024
|
Erica Mallon General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
36,000
+50.0%
|
-
|
|
Jul 16
2024
|
Todd Schonherz Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+49.56%
|
-
|
|
May 24
2024
|
Stephen Divers Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+7.41%
|
$10,000
$2.15 P/Share
|
|
May 21
2024
|
Todd Schonherz Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,340
+24.22%
|
$5,340
$1.86 P/Share
|
|
May 04
2024
|
Bradley M Fluegel Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,981
+27.26%
|
-
|
|
May 04
2024
|
William Valle Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,981
+50.0%
|
-
|
|
Mar 20
2024
|
Stephen Divers Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,554
-12.96%
|
$42,770
$5.7 P/Share
|
|
Mar 19
2024
|
Stephen Divers Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
59,500
+47.4%
|
$297,500
$5.69 P/Share
|
|
Jan 05
2024
|
Stephen Divers Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,369
-34.05%
|
$20,214
$6.1 P/Share
|
|
Jan 03
2024
|
American Oncology Network, Inc. Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,893
+50.0%
|
-
|
|
Sep 25
2023
|
Saba Capital Management, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
205,512
-100.0%
|
$2,055,120
$10.5 P/Share
|
|
Sep 20
2023
|
Digital Transformation Sponsor LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
8,112,500
+50.0%
|
-
|
|
Sep 20
2023
|
Bradley M Fluegel Director |
BUY
Other acquisition or disposition
|
Direct |
25,000
+50.0%
|
-
|
Last 12 Months Summary
Buy / Acquisition
572K
Shares
From
8
Insiders
| Grant, award, or other acquisition | 562K shares |
|---|---|
| Open market or private purchase | 10.3K shares |
Sell / Disposition
0
Shares
From
0
Insiders